WuXi Biotech Firm Sells Facility Ahead of US Legislation Ban
Chinese biotech firm WuXi plans to sell its Ireland facility to Merck for $500 million as the BioSecure Act advances through the Senate and awaits presidential approval.
What would you like to watch today?